Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials.
The DOI matches its Crossref record.
Abstract
PURPOSE: Here we report the results of a randomized study undertaken to test the efficacy of a supplementary, telephone-based nursing intervention in increasing patients' awareness and understanding of the clinical trials in which they are asked to participate. METHODS: During a 12-month period, 180 cancer patients who were approached to participate in a phase II or III clinical trial were randomized to undergo either of the following: (1) standard informed consent procedures based on verbal explanations from the treating physician plus written information (controls); or (2) standard informed consent procedures plus a supplementary, telephone-based contact with an oncology nurse (intervention). For purposes of evaluation, face-to-face interviews were conducted with all patients approximately 1 week after the informed consent process had been completed. RESULTS: The two groups were comparable with regard to sociodemographic and clinical variables. Both groups had a high level of awareness of the diagnosis and of the nature and objectives of the proposed treatments. The intervention group was significantly (P < .01) better informed about the following: (1) the risks and side effects of treatment; (2) the clinical trial context of the treatment; (3) the objectives of the clinical trial; (4) where relevant, the use of randomization in allocating treatment; (5) the availability of alternative treatments; (6) the voluntary nature of participation; and (7) the right to withdraw from the clinical trial. The intervention did not have any significant effect on patients' anxiety levels or on rates of clinical trial participation. Patients reported high levels of satisfaction with the intervention. CONCLUSION: The use of a supplementary, telephone-based nursing intervention is a feasible and effective means to increase cancer patients' awareness and understanding of the salient issues that surround the clinical trials in which they are asked to participate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Flory, J., & Emanuel, E. (2004) · JAMA · doi:10.1001/jama.292.13.1593 · Cited by 1,067
Barriers to Participation in Randomised Controlled Trials
Ross, S., Grant, A., Counsell, C., Gillespie, W., Russell, I., & Prescott, R. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00141-9 · Cited by 907
Quality of informed consent in cancer clinical trials: a cross-sectional survey
Joffe, S., Cook, E. F., Cleary, P. D., Clark, J. W., & Weeks, J. C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06805-2 · Cited by 655
Strategies to improve recruitment to randomised trials
Treweek, S., Pitkethly, M., Cook, J., Fraser, C., Mitchell, E., Sullivan, F., Jackson, C., Taskila, T. K., & Gardner, H. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000013.pub6 · Cited by 521
Nishimura, A., Carey, J., Erwin, P. J., Tilburt, J. C., Murad, M. H., & McCormick, J. B. (2013) · BMC Medical Ethics · doi:10.1186/1472-6939-14-28 · Cited by 521
Factors that limit the quality, number and progress of randomised controlled trials
Prescott, Counsell, Gillespie, Grant, Russell, Kiauka, Colthart, Ross, Shepherd, & Russell (1999) · Health Technology Assessment · doi:10.3310/hta3200 · Cited by 390
Strategies to improve recruitment to randomised controlled trials
Treweek, S., Mitchell, E., Pitkethly, M., Cook, J., Kjeldstrøm, M., Johansen, M., Taskila, T. K., Sullivan, F., Wilson, S., Jackson, C., et al. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000013.pub5 · Cited by 378
Improvement of informed consent and the quality of consent documents
Jefford, M., & Moore, R. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70128-1 · Cited by 336
Informed decision making: an annotated bibliography and systematic review.
Bekker, Thornton, Airey, Connelly, Hewison, Robinson, Lilleyman, MacIntosh, Maule, Michie, et al. (1999) · Health Technology Assessment · doi:10.3310/hta3010 · Cited by 335
Increasing recruitment to randomised trials: a review of randomised controlled trials
Watson, J. M., & Torgerson, D. J. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-34 · Cited by 332
Strategies for Increasing Recruitment to Randomised Controlled Trials: Systematic Review
Caldwell, P. H. Y., Hamilton, S., Tan, A., & Craig, J. C. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000368 · Cited by 307
“Halpern [47] AUS$2,000 incentive 10% risk of adverse effects 35/64 55% (42–67) 20% risk of adverse effects 29/64 45% (33–58) 1.”
BackgroundInfluentialSnowdon, C., Garcia, J., & Elbourne, D. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(97)00063-4 · Cited by 296
Mistiaen, P., & Poot, E. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004510.pub3 · Cited by 299
The therapeutic misconception: problems and solutions.
Lidz, C. W., & Appelbaum, P. S. (2002) · PubMed · doi:10.1097/01.mlr.0000023956.25813.18 · Cited by 267
Ellis, P. M. (2000) · Annals of Oncology · doi:10.1023/a:1008342222205 · Cited by 260
Brehaut, J. C., Kohen, D. E., Garner, R. E., Miller, A. R., Lach, L. M., Klassen, A. F., & Rosenbaum, P. L. (2009) · American Journal of Public Health · doi:10.2105/ajph.2007.129817 · Cited by 254
Follow-up for people with cancer: nurse-led services and telephone interventions
Cox, K., & Wilson, E. (2003) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2003.02672.x · Cited by 191
“The intervention group was significantly better informed about side-effects, the way in which treatment was to be given and the frequency of treatment (Aaronson et al. 1996).”
BackgroundSocial support and suicidal ideation in older adults using home healthcare services
Rowe, J. L., Conwell, Y., Schulberg, H. C., & Bruce, M. L. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000218324.78202.25 · Cited by 153
Improving Participant Comprehension in the Informed Consent Process
Cohn, E., & Larson, E. (2007) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2007.00180.x · Cited by 115
“Agre and Rapkin (2003) measured comprehension of consent information among 204 participants who were randomized to one of four consent processes: standard, video, computer-assisted instruction, or booklet.”
BackgroundThe mobile phone as a tool in improving cancer care in Nigeria
Odigie, V. I., Yusufu, L. M. D., Dawotola, D. A., Ejagwulu, F., Abur, P., Mai, A., Ukwenya, Y., Garba, E. S., Rotibi, B. B., & Odigie, E. C. (2012) · Psycho-Oncology · doi:10.1002/pon.1894 · Cited by 74
Radical prostatectomy: men's experiences and postoperative needs
Burt, J., Caelli, K., Moore, K., & Anderson, M. (2005) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2005.01123.x · Cited by 75
Knowledge and understanding among cancer patients consenting to participate in clinical trials
Bergenmar, M., Molin, C., Wilking, N., & Brandberg, Y. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.08.013 · Cited by 62
Jefford, M., Mileshkin, L., Matthews, J., Raunow, H., O’Kane, C., Cavicchiolo, T., Brasier, H., Anderson, M., & Reynolds, J. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0829-6 · Cited by 55
Bergenmar, M., Johansson, H., & Wilking, N. (2011) · Clinical Trials · doi:10.1177/1740774510384516 · Cited by 49
“In contrast to other studies neither education level [7,9,11], nor signing the consent form at the first visit, or the presence of a nurse at the consent discussion were associated with knowledge level in the present study [11].”
ResultAnimations about Clinical Trial Participation for Cancer Patients and Survivors
Occa, A., & Morgan, S. E. (2019) · Journal of Health Communication · doi:10.1080/10810730.2019.1668089 · Cited by 19
Pragmatic Comparative Effectiveness Trials and Learning Health Systems in Pain Medicine
Salmasi, V., Terkawi, A. S., & Mackey, S. C. (2023) · Anesthesiology Clinics · doi:10.1016/j.anclin.2023.03.010 · Cited by 16
O'Sullivan Greene, E., & Shiely, F. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2022.10.014 · Cited by 11
Metadata
- Authors
- Aaronson, N. K., Visser-Pol, E., Leenhouts, G. H., Muller, M. J., van der Schot, A. C., van Dam, F. S., Keus, R. B., Koning, C. C., ten Bokkel Huinink, W. W., van Dongen, J. A., & Dubbelman, R.
- Venue
- Journal of Clinical Oncology
- Published
- 1996-03
- Volume
- 14
- Issue
- 3
- Pages
- 984-996
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1836438867
- Cited by
- 184
- References
- 0
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.